How many stocks does Quadrature Capital Ltd own?

As of Q4 2025, Quadrature Capital Ltd holds 1,217 positions in their 13F portfolio.

What is Quadrature Capital Ltd's largest holding?

AMD at 3.0% of portfolio, worth $296.6M.

What is Quadrature Capital Ltd's total portfolio value?

$9.8B as of Q4 2025, tracked across 1,217 holdings.

Is Quadrature Capital Ltd a hedge fund?

Quadrature Capital Ltd is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does Quadrature Capital Ltd report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has Quadrature Capital Ltd's portfolio changed in Q4 2025?

View Quadrature Capital Ltd's latest portfolio changes, new positions, and exits for Q4 2025 on HoldingsIntel.

What is Quadrature Capital Ltd's investment strategy?

Quadrature Capital Ltd is classified as a Momentum Trader fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

Quadrature Capital Ltd Holdings Q4 2025 - Portfolio & Conviction Scores | HoldingsIntel

Quadrature Capital Ltd

Institutional investor · Portfolio as of Q4 2025

Weak(1.0 / 5.0)

$9.8B

AUM

1,217

Positions

759

New

Q4 2025

Filing Period

Quarterly Portfolio Change

SEC EDGAR SourceSEC Filings

Quadrature Capital Ltd manages $9.8B across 1217 positions as of Q4 2025. Top holdings: AMD (3.0%), UNH (3.0%), MU (2.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.

Q4 2025 Summary

Active quarter - 759 new positions, 535 exits, 261 increased. Top move: AMD (INCREASED, conviction 90). Portfolio: $9.8B across 1217 positions.

Portfolio Allocation

Top holdings by portfolio weight

AMD3.03%

UNH2.97%

MU2.40%

LLY2.37%

CNI2.29%

SNDK2.03%

ASML2.00%

GEV1.80%

TSLA1.69%

STLA1.61%

Other1.60%

Similar Funds

Funds with similar investing DNA

Third Point LLC

$7.3B

DRIEHAUS CAPITAL MANAGEMENT LLC

$14.7B

+3 more

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

IBRX2Q held

ImmunityBio, Inc.

Avg $2.33 · $3.3M est. P&L

Est. P&L

+328.38%

LITE2Q held

Lumentum Holdings Inc.

Avg $162.58 · $3.2M est. P&L

Est. P&L

+327.13%

UAMY4Q held

United States Antimony Corporat

Avg $2.32 · $103,249 est. P&L

Est. P&L

+313.18%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Top Holdings10 of 1217

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
AMD Advanced Micro Devices, Inc.	1.4M	$296.6M	3.0%	—	$182.83	+4.44%	4 qtrssince 2025-Q1	Increased 90
UNH UnitedHealth Group Incorporated	882,161	$291.2M	3.0%	—	$332.16	-12.93%	1 qtr	New 80
MU Micron Technology, Inc.	822,996	$234.9M	2.4%	—	$137.67	+175.78%	3 qtrssince 2025-Q2	Increased 56
LLY Eli Lilly and Company	215,864	$232M	2.4%	—	$888.10	+13.47%	2 qtrssince 2025-Q3	Increased 82
CNI Canadian National Railway Compa	2.3M	$223.9M	2.3%	—	$95.60	+16.29%	7 qtrssince 2024-Q2	Increased 66
SNDK Sandisk Corporation	839,507	$199.3M	2.0%	—	$181.92	+210.81%	3 qtrssince 2025-Q2	Increased 85
ASML ASML Holding N.V. - New York Re	183,199	$196M	2.0%	—	$1,029.60	+32.18%	3 qtrssince 2025-Q2	Increased 84
GEV GE Vernova Inc.	269,679	$176.3M	1.8%	—	$613.28	+37.29%	5 qtrssince 2024-Q4	Increased 77
TSLA Tesla, Inc.	367,065	$165.1M	1.7%	—	$443.21	-11.46%	2 qtrssince 2025-Q3	Decreased 0
STLA Stellantis N.V.	14.2M	$158M	1.6%	—	$9.37	-20.04%	4 qtrssince 2025-Q1	Decreased 0
Showing 10 of 1,217 results.1,207 more with Pro.PROUpgrade to see all →